ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003